Valuation: Enovis Corporation

Market Cap 1.04B 909M 854M 780M 1.46B 99.46B 1.46B 10.26B 3.96B 50.79B 3.91B 3.82B 164B P/E 2026 *
89.3x
P/E 2027 * 23.1x
Enterprise Value 2.34B 2.05B 1.93B 1.76B 3.3B 224B 3.3B 23.11B 8.92B 114B 8.8B 8.61B 369B EV / Sales 2026 *
1x
EV / Sales 2027 * 0.92x
Free-Float
98.36%
Yield 2026 *
-
Yield 2027 * -
1 day+1.36%
1 week+1.51%
Current month-25.95%
1 month-27.77%
3 months-14.51%
6 months-19.10%
Current year-31.64%
1 week 17.47
Extreme 17.47
19.26
1 month 17.3
Extreme 17.3
26.93
Current year 17.3
Extreme 17.3
31.66
1 year 17.3
Extreme 17.3
34.28
3 years 17.3
Extreme 17.3
65.03
5 years 17.3
Extreme 17.3
164.01
10 years 17.3
Extreme 17.3
164.01
Manager TitleAgeSince
Chief Executive Officer 61 2025-05-11
Director of Finance/CFO 47 2022-12-31
Chief Tech/Sci/R&D Officer - 2025-12-31
Director TitleAgeSince
Director/Board Member 55 2008-05-12
Director/Board Member 67 2010-09-20
Chairman 64 2025-05-20
Date Insider Type Main position Quantity % Market Cap. Importance
9/4/26 Buy

Chief Administrative Officer

2,660 0.0047%
9/4/26 Buy

Chief Executive Officer

13,035 0.0228%
9/3/26 Buy

Chief Administrative Officer

5,140 0.0090%
Change 5-day change 1-year change 3-year change Capi.($)
+1.27%+1.51%-43.71%-64.74% 1.04B
+0.56%-1.84%-26.94%-3.14% 105B
-0.34%-0.67%-23.64%-0.77% 11.63B
-0.35%-6.11%+90.49%+114.12% 9.52B
-0.52%+5.55%-50.01%-66.86% 4.22B
+2.40%+3.36%-24.63%+25.14% 2.39B
-4.42%-2.75%-7.61%-60.78% 2.19B
+1.53%+7.78% - - 1.96B
-0.58%+2.75%-19.33%-27.67% 1.55B
Average -0.03%+1.26%-13.17%-10.59% 15.52B
Weighted average by Cap. +0.35%-2.15%-18.95%+2.04%

Financials

2026 *2027 *
Net sales 2.34B 2.04B 1.92B 1.75B 3.29B 224B 3.29B 23.06B 8.9B 114B 8.79B 8.59B 368B 2.45B 2.14B 2.02B 1.84B 3.45B 235B 3.45B 24.19B 9.34B 120B 9.22B 9.01B 386B
Net income 11.32M 9.9M 9.3M 8.49M 15.93M 1.08B 15.93M 112M 43.08M 553M 42.53M 41.6M 1.78B 39M 34.08M 32.03M 29.23M 54.86M 3.73B 54.87M 384M 148M 1.9B 146M 143M 6.14B
Net Debt 1.3B 1.14B 1.07B 978M 1.83B 125B 1.84B 12.86B 4.96B 63.67B 4.9B 4.79B 205B 1.21B 1.06B 996M 909M 1.71B 116B 1.71B 11.95B 4.61B 59.19B 4.55B 4.45B 191B
Logo Enovis Corporation
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Employees
7,802
Date Price Change Volume
26-09-22 US$18.18 +0.78% 615,516
26-09-21 US$18.04 0.00% 2,593,888
26-09-18 US$18.04 +1.35% 2,645,397
26-09-17 US$17.80 -4.61% 2,229,589
26-09-16 US$18.66 +4.01% 1,812,205
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
18.04USD
Average target price
38.33USD
Spread / Average Target
+112.49%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ENOV Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!